Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in France with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Unknown status Country / region: France Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20061
20071
20082
20092
20101
20111
20121
20131
20142
20151
20162
20173
20184
20193
20201
20213
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Institut Paoli-Calmettes5
Hospices Civils de Lyon4
Assistance Publique - Hôpitaux de Paris3
Nantes University Hospital3
Groupe Francophone des Myelodysplasies2
Assistance Publique Hopitaux De Marseille1
Centre Hospitalier Universitaire, Amiens1
Facet Biotech1
French Innovative Leukemia Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute40
Leukemia9
Myelodysplastic Syndromes7
Leukemia, Monocytic, Acute6
Leukemia, Myelomonocytic, Acute6
Leukemia, Erythroblastic, Acute5
Leukemia, Megakaryoblastic, Acute5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Congenital Abnormalities4
Hematologic Neoplasms3

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.